|
US4039549A
(en)
*
|
1975-03-18 |
1977-08-02 |
Merrell Toraude Et Compagnie |
Olefinic derivatives of amino acids
|
|
US4041041A
(en)
*
|
1975-03-18 |
1977-08-09 |
Merrell Toraude Et Compagnie |
Acetylene derivatives of amino acids
|
|
US4139563A
(en)
*
|
1977-07-01 |
1979-02-13 |
Merrell Toraude Et Compagnie |
α-ACETYLENIC DERIVATIVES OF AMINES
|
|
US4147873A
(en)
*
|
1977-07-01 |
1979-04-03 |
Merrell Toraude Et Compagnie |
α-Vinyl derivatives of α-amino acids
|
|
CA1157030A
(en)
*
|
1977-07-01 |
1983-11-15 |
Brian W. Metcalf |
.alpha.-VINYL AMINO ACIDS
|
|
CA1121375A
(en)
*
|
1977-07-01 |
1982-04-06 |
Brian W. Metcalf |
Derivatives of amines and amino acids
|
|
US4326071A
(en)
*
|
1977-09-28 |
1982-04-20 |
Merrell Toraude Et Compagnie |
Halomethyl derivatives of gamma-aminobutyric acid and related compounds
|
|
US4187316A
(en)
*
|
1978-01-12 |
1980-02-05 |
Merrell Toraude Et Compagnie |
Substituted 1,5-cyclohexadiene carboxylic acid derivatives
|
|
US4178463A
(en)
*
|
1978-01-30 |
1979-12-11 |
Merrell Toraude Et Compagnie |
Process for making 4-aminohex-5-enoic acid
|
|
US4254284A
(en)
*
|
1978-01-30 |
1981-03-03 |
Merrell Toraude Et Compagnie |
Process for preparing 4-aminohex-5-ynoic acid
|
|
US5147868A
(en)
*
|
1978-07-24 |
1992-09-15 |
Merck & Co., Inc. |
Thienamycin renal peptidase inhibitors
|
|
US4880793A
(en)
*
|
1978-07-24 |
1989-11-14 |
Merck & Co., Inc. |
Combination of thienamycin-type antibiotics with dipeptidase inhibitors
|
|
US4323704A
(en)
*
|
1979-06-25 |
1982-04-06 |
Merrell Toraude Et Compagnie |
αAcetylene and α-vinyl derivatives of amino acids
|
|
US4539208A
(en)
*
|
1980-09-17 |
1985-09-03 |
Merck & Co., Inc. |
Combination of thienamycin-type antibiotics with dipeptidase inhibitors
|
|
US4372974A
(en)
*
|
1980-06-25 |
1983-02-08 |
New York University |
Anticonvulsive compositions and method of treating convulsive disorders
|
|
GB2120244B
(en)
*
|
1982-05-17 |
1985-05-01 |
Merrell Toraude & Co |
Aminoalkadiene derivative
|
|
GB2133002B
(en)
*
|
1982-12-30 |
1986-01-29 |
Merrell Toraude & Co |
Process for preparing 4-amino-5-hexenoic acid
|
|
GB8311804D0
(en)
*
|
1983-04-29 |
1983-06-02 |
Merrell Toraude & Co |
Treatment of seizure disorders and pharmaceutical compositions
|
|
US4668703A
(en)
*
|
1983-07-07 |
1987-05-26 |
Syntex (U.S.A.) Inc. |
γ-allenyl-γ-aminobutyric acids
|
|
ES8605468A1
(es)
*
|
1983-07-07 |
1986-04-01 |
Syntex Inc |
Procedimiento para preparar acidos -alenil- -aminobutiricos
|
|
US4661510A
(en)
*
|
1983-08-17 |
1987-04-28 |
Syntex (U.S.A.) Inc. |
α-allenic-α-amino acids as enzyme inhibitors
|
|
US4588825A
(en)
*
|
1983-10-11 |
1986-05-13 |
Merrell Dow Pharmaceuticals Inc. |
Intermediates for the synthesis of 4-amino-4,5-dihydro-2-furancarboxylic acid
|
|
US4632994A
(en)
*
|
1983-11-04 |
1986-12-30 |
Gruppo Lepetit S.P.A. |
Process for decomposing N-oxide derivatives producing 5-vinyl-2-pyrrolidones
|
|
JPS6137389U
(ja)
*
|
1984-08-09 |
1986-03-08 |
永大産業株式会社 |
家具用の戸
|
|
DE3536146A1
(de)
*
|
1985-10-10 |
1987-04-16 |
Degussa |
Verfahren zur enantioselektiven herstellung von (alpha)-vinyl-(alpha)-aminocarbonsaeuren
|
|
US4806680A
(en)
*
|
1986-03-17 |
1989-02-21 |
Merck & Co., Inc. |
3-halovinylglycine antibacterial agents
|
|
US4727062A
(en)
*
|
1986-03-17 |
1988-02-23 |
Merck & Co., Inc. |
3-Halovinylglycine antibacterial agents
|
|
AU629419B2
(en)
|
1989-11-07 |
1992-10-01 |
Aventis Inc. |
Process for the production of vinyl-gaba
|
|
AU644919B2
(en)
*
|
1990-12-17 |
1993-12-23 |
Aventisub Ii Inc. |
Process for the production of (S)-vinyl and allenyl gaba
|
|
US5208345A
(en)
*
|
1990-12-17 |
1993-05-04 |
Merrell Dow Pharmaceuticals Inc. |
Process for the production of (S)-vinyl and allenyl gaba
|
|
EP0546230A1
(en)
*
|
1991-12-10 |
1993-06-16 |
Merrell Dow Pharmaceuticals Inc. |
Novel process for preparing 4-amino-5-hexenoic acid
|
|
US5705660A
(en)
*
|
1994-08-22 |
1998-01-06 |
Board Of Regents, University Of Nebraska-Lincoln |
Method for the synthesis of α-oxiranyl amino acids
|
|
US7098206B2
(en)
*
|
1998-01-21 |
2006-08-29 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
|
US6998400B2
(en)
*
|
1998-01-22 |
2006-02-14 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
|
CA2318920A1
(en)
*
|
1998-01-29 |
1999-08-05 |
James W. Young |
Pharmaceutical uses of optically pure (-)-bupropion
|
|
JP2002501891A
(ja)
|
1998-01-29 |
2002-01-22 |
セプラコア インコーポレーテッド |
光学的に純粋な（＋）−ビュープロピオンの医薬用途
|
|
US6541520B1
(en)
|
1998-08-05 |
2003-04-01 |
Brookhaven Science Associates |
Treatment of addiction and addiction-related behavior
|
|
US6855820B2
(en)
|
1999-01-20 |
2005-02-15 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
|
US6734213B2
(en)
|
1999-01-20 |
2004-05-11 |
Smithkline Beecham Corporation |
Pharmaceutically active morpholinol
|
|
US6337328B1
(en)
|
1999-03-01 |
2002-01-08 |
Sepracor, Inc. |
Bupropion metabolites and methods of use
|
|
US6342496B1
(en)
*
|
1999-03-01 |
2002-01-29 |
Sepracor Inc. |
Bupropion metabolites and methods of use
|
|
AU2002215160A1
(en)
|
2000-11-30 |
2002-06-11 |
Pfizer Products Inc. |
Combination of gaba agonists and aldose reductase inhibitors
|
|
AU2002215159A1
(en)
|
2000-11-30 |
2002-06-11 |
Pfizer Products Inc. |
Combination of GABA agonists and sorbitol dehydrogenase inhibitors
|
|
MXPA05012317A
(es)
*
|
2003-05-16 |
2006-01-30 |
Pfizer Prod Inc |
Combinaciones terapeuticas de agentes antipsicoticos atipicos con agentes moduladores del gaba anticonvulsivos o benzodiazepinas.
|
|
DK1691811T3
(da)
|
2003-12-11 |
2014-10-20 |
Sunovion Pharmaceuticals Inc |
Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
|
|
BRPI0507190A
(pt)
*
|
2004-01-29 |
2007-06-26 |
Pfizer Prod Inc |
combinação de moduladores do ácido gama-aminobutìrico e antagonistas de 5-ht1b receptores
|
|
EP2258357A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
CA2620333A1
(en)
|
2005-08-26 |
2007-03-01 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
WO2007047978A2
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
EP2314289A1
(en)
|
2005-10-31 |
2011-04-27 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US7678808B2
(en)
|
2006-05-09 |
2010-03-16 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
|
CA2651813A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
EP2068872A1
(en)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
CN101631768A
(zh)
*
|
2007-03-15 |
2010-01-20 |
太阳医药高级研究有限公司 |
新型前药
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
EP2537827B1
(en)
|
2011-06-24 |
2014-06-11 |
Targeon SAS |
Process for preparing 4-amino-5-hexenoic acid from succinimide
|